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ABSTRACT
In recent years the frequency of antibiotic resistance has been on the rise creating a need for
antibiotic development with specific and lethal targets. It has been recently reported that
glycosyl trizole are a novel class of antibacterial agents (1). Further investigation on the
antibacterial ability of glycosyl triazole inhibitors has shown that targets include exo-acting
N-acetylglucosaminidases (GlcNAcase) LytG (Bacillus subtilis) and FlgJ (Salmonella
enterica) of the GH73 family (2). The Glycoside Hydrolase Family 73 (GH73) is
characterized by bacterial and viral glycoside hydrolase. This enzyme cleaves the β-1,4glycosidic linkage between N-acetylglucosaminyl (NAG) and N-acetylmuramyl (NAM) of the
carbohydrate backbone in bacterial peptidoglycan. Glycoside hydrolase can occur as an endoor exo- process, depending on the region of the chain that is cleaved. Endo-acting refers to
activity in the middle of the chain, whereas exo-acting refers to the ends (typically the nonreducing end) (3). Currently, there is no kinetic parameters that have been determined for any
member of the GH73 family, however binding and kinetic characterization will be performed
for select glycosyl triazole inhibitors and GH73 targets interactions. Further studies will
involve crystallization and GlcNAcase activity assays to identify GH73 family members as
the target of glycosyl triazole inhibitors. Through these studies the interaction between the
non-competing inhibitor and the GH73 target will be characterized. Additionally, it will be
demonstrated that these Ugi- derived compounds are competitive inhibitors of GH73
enzymes.
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INTRODUCTION
Peptidoglycan is one of the most important elements of the cell that protects its’ integrity and
shape as well as maintains its electrolyte balance and confer stability and strength. When the
peptidoglycan layer within the cell is inhibited or interfered with the cell may even signal
certain pathways that will initiate apoptosis. Being such an integral part of the cells ability to
survive, peptidoglycan serves as an ideal target for antibiotic compounds. While many have
been clinically successful with exploiting this target (including vancomycin and β-lactams),
one target in particular has been left unexploited- N-acetylglucosaminidase (GlcNAcases).
This bacterial autolysins is an important element, responsible for making space for
incorporating new material into the cell as well as assisting in cell division which may include
vegetative growth, daughter cell separation or hydrolysis of the septum upon separation (5).
Since GlcNAcase is such a vital aspect of the cell, we chose it as our target. Preliminary data
has resulted in the filing of a provisional patent (1) which encompasses the use of diamide
inhibitors against Gram-positive bacteria. The widespread and inappropriate use of antibiotics
have rendered the world almost powerless against antibiotic resistant strains and the newest
‘superbugs’. Every year in the United States alone antibiotic resistant strains cause 23,000
deaths and an estimated $20 billion in additional health care cost (6).

LITERATURE REVIEW
Gram Staining
Through the process of Gram staining, bacterial species can be differentiated into the two
groups of Gram- negative and Gram-positive. Differing these two categories is the
characteristics of the layers peptidoglycan within the cell wall, capitalizing of this
differentiation, Gram- staining detects peptidoglycan. This procedure begins with the airdried, fixed bacterial smears being stained with crystal violet stain and rinsed which turns
both Gram-positive and Gram- negative cells purple. Additionally, an iodine solution is then
added to the smear and rinsed which turns both cell types a blue-purple. Next, an alcohol
wash is added which is what begins differentiating Gram-positive from Gram- negative
bacteria. The Gram-positive cells contain a thick layer of peptidoglycan which resists the
effects of the alcohol wash and maintains the blue-purple coloring. Contrastingly, Gram-2-
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negative cells have a much thinner layer of peptidoglycan and losses the blue-purple staining.
Finally, the last step is the addition of Safranin, an orange- red stain. This is picked up by the
Gram- negative bacteria, but again Gram-positive bacteria resists the coloring and remains
blue-purple (7). This staining technique is an empirical method that relies solely on the
detection of the outer lipid membrane (8).

Figure 1 : This image depicts the process of Gram staining and the subsequent coloring that
results in both Gram- positive and Gram- negative species at each step of the procedure(9).

Gram-negative and Gram-positive Bacteria
Gram – negative bacteria consist of a thin layer of peptidoglycan that is paired with an outer
membrane with lipopolysaccharide (LPS) which contains lipid A, a core polysaccharide and
an O antigen. LPS, an endotoxin, and is a major facet to the structural integrity of bacteria and
the protection of the cell membrane. In Gram- negative bacteria this component of the cell
wall is absolutely vital to the life of the cell and if this structure is destroyed or mutated the
result would be cell death. Further differentiating the Gram-positive from the Gram-negative
is the presence of an outer membrane and the relative thinness of the cell wall (ranging from
only 8-12nm thick compared to Gram- positive bacteria which ranges closer to 20-30nm
thick). The cell wall of Gram-negative bacteria is also wavy and is only tethered to the plasma
membrane at a select few locations, rather than tightly bound and smooth in Gram-positive
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bacteria (10). Additionally, unique to Gram-negative bacteria is the porins that are present in
the outer membrane. These porins are beta barrel proteins that channel through the plasma
membrane and act as pores allowing for passive diffusion of water, ions and some small
molecules (10). Finally, the absence of teichoic acid within Gram-negative species
differentiates from the Gram-positive cell walls in which it is present within the peptidoglycan
layer (11). It should be noted that these characteristics are mere guidelines and have
exceptions.

Figure 2: This image demonstrates the physical structural differences between Gram- positive
and Gram- negative bacterial cell wall including the presence (or absence) of techoic acid,
lipotechoic acid and porins (12).
Bacillus subtilis
Bacillus subtilis (B. subtilis) is commonly found in soil, water and the gastrointestinal tracts
of various organisms including humans. In severely immune-compromised individuals, the
presence of B. subtilis can cause harmful effects, contrastingly it can also be used as a
probiotic in individuals who are not immune-compromised (13). B. subtilis is extremely
resistant to heat exposure which is evident through the plethora of strains that are found in
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spoiled bread known as ‘roping’ which results in the sticky production of long- chain
polysaccharides due to B. subtilis (14). B. subtilis is also a facultative aerobe, meaning that it
can grow and survive in both aerobic and anaerobic environments. In anaerobic instances, the
cell will use nitrite or nitrate as the terminal electron acceptor instead of oxygen. This
catalase positive species converts hydrogen peroxide into components that won’t have the
damaging effects of hydrogen peroxide has on cellular metabolic process.
The use of flagella allows for cells to swarm on surfaces, but not liquids. When B. subtilis
connects with neighboring cells they lose their ability to move individually and thus must
move as a cohort, referred to as a ‘raft’. A slime layer containing surfactin, a lipopeptide that
is able to reduce surface tension, must first be secreted before the B. subtilis rafts are able to
move (15).

Figure 3: Shown here is a micrograph of Bacillus subtilis containing both vegetative cells and
endospores (16).
B. subtilis is viewed as an exemplary model to study fundamental properties and
characteristics of typical Gram-positive spore- forming bacteria. B. subtilis is able to ferment
quickly with high product yield which also makes it an ideal organism to work with.
Endospore formation studies also frequently use B. subtilis as the model organism since they

-5-

Biochemical Characterization of Diamide Inhibitors with N-acetylglucosaminidases
LytG from Bacillus subtilis)
Senior Capstone Project for Drew Phelan
are found mostly in the tips of protuberances. Particularly helpful in cellular development and
differentiation experimentation, B. subtilis will also be an ideal organism for studying
GlcNAcase due to its indirect involvement in the cell division. The ease of genetic mutation
that is associated with B. subtilis also promotes it as a model organism for laboratory work.

Figure 4: During the vegetative cycle the B. subtilis cell medially divides and grow; next the
cell regulator determines if it remains in the vegetative cycle or proceeds into the sporulation
cycle. This cycle begins with asymmetric cell division with the formation of a relatively
smaller prespore and a mother cell. The mother cell then engulfs the prespore, deposits a
spore coat and the mother cell lyses. This releases the spore and it then can germinate in
favorable environments which brings the cell back into the vegetative cycle (17).
Peptidoglycan in Gram-positive Bacteria
In Gram-positive bacteria this layer of peptidoglycan is thick can often be anywhere from 1580 nanometers, compared to the relatively thin layer found in Gram-negative bacteria, which
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typically consists of a single layer about 10 nanometers thick. Gram-negative peptidoglycan
is formed with a carbohydrate backbone that alternates N-acetylglucosamine (GlcNAc) and
N-acetyl muramic acid (MurNAc); together these amino acid sugars are linked by β-(1,4)glycosidic bond. The 3- carbon in MurNAc is substituted for a lactyl ether group, which is
derived from pyruvate, which then is able to connect the glycan backbone to a peptide side
chain. This peptide side chain contains L-alanine, D-glutamate, Diaminopimelic acid and Dalanine in which D-glutamate, D-alanine and Diaminopimelic acid, as well as MurNAc, are
only found in bacterial cells. Neighboring peptide side chains are able to link together through
an interpeptide bond between Diaminopimelic acid and D-alanine due to the free amino group
on Diaminopimelic acid and the free carboxy group on D-alanine (18). This allows for the
strands of peptidoglycan to connect, forming a continuous layer around the cell.
Gram-positive peptidoglycan structure can vary, however the most common composition
(found in S. aureus and B. subtilus) consists of diamino acid instead of Diaminopimelic acid
and L-lysine; instead of an interpeptide bond, there is an interpeptide bridge of amino acids.
This bridge links the free amino group found on the L-lysine with the free carboxy group,
again, found on the D-alanine. It has been found that this interpeptide bridge allows for a
higher frequency of cross-bonding between neighboring peptide side chains. Specifically, S.
aureus consists of an interpeptide bridge with a 5 glycine molecule, referred to a pentaglycine
bridge (18).
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Figure 5: This animation demonstrates the fundamental differences between the
peptidoglycan structure of Gram- negative and Gram- positive organisms based on the
composition of peptides(19).
Teichoic Acid
Teichoic acid is tightly associated with the formation of the peptidoglycan layer in Grampositive species. Consisting of polyglycerol or polyribitol with phosphate substitutes and
amino acids sugars, Teichoic acid’s exact function still remains unknown. It has been
proposed that they regulate and mediate positively charged substances through the network of
peptidoglycan layers by providing negatively charged channels. Since Teichoic acid is known
to occasionally attach to the plasma membrane and protrude into the layers of peptidoglycan,
forming lipoteichoic acid, this theory holds substantial merit. Further, it is suggested that they
regulate and assemble murmic acid to the outside of the plasma membrane, thereby able to
assist in the adherence to tissue surfaces.
Peptidoglycan Biosynthesis
It has also been found that antibiotics targeting the biosynthesis of peptidoglycan, particularly
the assembly of interpeptide bridge and bond, is much more efficient in Gram-positive
bacteria, compared to Gram-negative. This can be explained by the generally higher
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abundance of peptidoglycan in Gram-positive bacteria, as well as the lack of the outer
membrane to protect the mesh- layer.
UDP-N-acetyl muramic acid, the precursor subunit of peptidoglycan is synthesized in the
cytoplasm, by adding a lactyl group to the 3- carbon of UDP-N-acetyl- glucosamine, UDP-Nacetyl muramic acid is formed. From there five amino acids are added, sequentially, with
enzymes rather than t-RNA, to the UDP-N-acetyl muramic acid which forms the pentapeptide
side chain, characteristic of S. aureus. In E. coli L-alanine is followed by D-glutamic acid,
meso-diaminopimelic acid, D-alanyl and D-alanine, however this order varies.
The NAM-peptide (pentapeptide or tripeptide) is then transferred from the UDP to
bactoprenol phosphate which is sitting on the membrane surface. NAG is then transferred
from UDP-NAG to bactoprenol-NAM-peptide which forms the final disaccharide-peptide
precursor. The complete NAM and NAG precursor is further transported by the bactoprenol
carrier lipid across the plasma membrane to the outer surface. This new disaccharide-peptide
is brought to the growing end of the peptidoglycan chain which lengthens it by a chain length.
As he bactoprenol pyrophosphate makes its way back through the plasma membrane into the
cytoplasm, one phosphate is removed by the enzyme, pyrophosphatase, which leaves the
bactoprenol-phosphate able to accept another NAM-peptide to continue the process (20,21).
The last step of this process is the linkage of the peptide side chains by either an interpeptide
bond or bridge, depending on Gram-negative or Gram-positive.
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Figure 6: Demonstrating the mechanisms and process of peptidoglycan biosynthesis (22).
Peptidoglycan Function
Functionally, peptidoglycan is responsible for the structural integrity and shape of the cell. A
cell is often placed in an environment with a varying osmotic pressure that can be hypertonic,
hypotonic or isotonic at times (23). The osmotic pressure is the necessary pressure in order to
prevent inward water flow across the membrane. Turgidity is the measure of the turgor
pressure, or the pressure that pushes the plasma membrane to the cell wall. When the cell is in
a hypertonic solution this means that the levels of solute are higher within the cell than the
environment so water flows out of the cell, thus shrinking and shriveling, losing turgidity. A
hypotonic solution is the opposite in which water flows into the cell, expanding it and
increasing the turgidity. Isotonic solutions are the middle ground between hypertonic and
hypotonic and allows for consistent turgidity as the rate or water flowing out is equal of that
flowing in. This varying environment can be extreme at times, causing osmotic lysis, or
cytolysis in hypotonic environment resulting in a bursting of the cell. The disaccharide
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polymer (glycan) being cross-linked with peptides makes it a flexible by strong net-like
membrane, thus making it crucial in the maintenance of osmotic pressure for cell integrity.
Further, peptidoglycan is related to diffusion of select molecules into the cell, regulation of
cell division, communication between cells and is covalently linked to teichoic acid (in Grampositive bacteria) and other proteins and polysaccharides (24).
During cell division, autolysins are critical in order to break the peptide cross links in
peptidoglycan allowing for binary fission to occur and the cell to split into two. These
enzymes are followed by transglycosylase enzymes which function to insert new peptide
monomers into the holes. Finally, transpeptidase enzymes reinforce the peptidoglycan by
reforming the peptide cross- links in the rows.
Antibiotic Resistance
Penicillin works at this last step and blocks transpeptidase from forming the peptide cross
links resulting in a weakened peptidoglycan layer which leads to cytolysis when the cell
encounters a hypotonic environment (25,26). Very soon after Penicillan’s discovery by Dr.
Alexander Fleming in 1928 did antibiotic resistance appear. Since, antibiotic resistances has
been on the rise due to the poor protocols and habits that have formed since antibiotics
introduction.
With emerging multi- drug resistant bacterial strains and a broad geographical location
affected have led to a new focus on drug development that prevents inducing bacterial
resistance (27). Antibiotic resistance has been linked to inappropriate use, inadequate
diagnosis, hospital and agricultural use. Often times, healthcare providers prescribe
antibiotics to their patients with a viral- like infection in hopes of eliciting a placebo effect.
Often times the antibiotic regime is not completed by the patient or outdated antibiotics are
self- prescribed. Both these instances lead to a weakened bacteriostatic impact and an
increased frequency of resistance. The heavy use of antimicrobial in elderly, infant,
immunosuppressed and ill patients also increases the frequency of antibacterial resistance as

- 11 -

Biochemical Characterization of Diamide Inhibitors with N-acetylglucosaminidases
LytG from Bacillus subtilis)
Senior Capstone Project for Drew Phelan
these antimicrobials select for the resistant bacteria, paired with the close quarters of patients
in elderly homes, hospitals and prisons, this provides an ideal environment for antibacterial
resistant bacteria to spread (28). Finally, the use of antibiotics in agricultural feed accelerates
resistance and in fact, more than half of the antibiotics that are created in the United States are
used for agricultural purposes (29).
Antibiotic resistance occurs naturally when selected organisms are able to withstand
the bacteriostatic characteristics of the antibiotic better than the susceptible cells which are
killed or inhibited, a fundamental Darwinian process. This results in selective pressure, the
influence that is exerted by antibiotics on the natural selection which promotes the resistant
organisms over the susceptible organisms (30).

Figure 7: Through the fundamental Darwanian process, antibiotic resistant strains of
bacteria are selected and multiplied (31).
Resistance can occur through one of two ways, genetic mutation or acquiring
resistance from other bacterium. Genetic mutations are rare and spontaneous changes that
occurs when non-resistant bacteria multiplies by the billions. It is estimated that only one
million out of every ten million cells are genetically mutated (32) which results in
100,000,000 mutated organisms in a sample size of one billion. These mutated organisms are
- 12 -
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selected for as they are resistant to the antibiotics, they multiply and the antibiotic resistant
strain of bacteria is now thriving and spreading (33).
Bacteria is also able to acquire antibiotic resistance from neighboring bacterium
through Horizontal Gene Transfer (HGT) which is achieved through three mechanisms:
transformation, conjugation and transduction. Transformation is the uptake of DNA from the
environment, though competency is necessary in order to do so. Some bacteria are able to
have competency induced through the addition of calcium chloride which pokes holes in the
membrane, or electroporation which delivers electric shocks creating an influx of ions
allowing for material (such as are subsequently sucked into the cell. Conjugation is the
process in which a cell- to – cell bridge is formed, referred to as a sex pilus which mediates
the exchange of F+/- plasmids. After the sex pilus is formed connecting the F+ (F plasmid,
male) to the F- (no F plasmid, female), the F plasmid in the male is snipped at the Origin of
Transfer (OriT) where relaxosomes then accompany the F plasmid, carrying antibiotic
resistant DNA, across the sex pilus. This now transforms the F- into a F+ and allows for the
transformed F+ to incorporate the antibiotic resistant DNA into its chromosomal DNA.
The third and final HGT mechanism, transduction, utilizes viruses as the vector for
chromosomal DNA fragment transfer. During the lytic cycle of the virus the host
chromosome is destroyed and the virus replicates themselves, subsequently killing the cell,
however, as the virus enters the lysogenic cycle, temperate phages integrate their DNA into
the host chromosome as a prophage. Generalized transduction allows for the phage DNA to
be immediately incorporated into the fragmented host chromosomes, fully virulent; DNA
fragments are accidently packaged into phages which results in defective phages. After the
cell lyses, transduction occurs only if the defective phage interacts with another cell and the
host DNA is then integrated and the process continues. In specialized transduction the host
chromosome is not fragmented, but instead cut in one place. After the prophage is extracted
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from the host chromosomes and replicated, the new phage contains host DNA and is able to
interact with neighboring cells to continue the process.

Figure 8: Horizontal Gene Transfer can occur in one of three ways depicted here (34).
There are several variations of antibiotic resistance and their mechanisms widely
contrast. The three most common mechanisms of antibiotic resistance are chemical
modification of the antibiotic, modification of target site or removal of the antibiotic, yielding
it ineffective. The chemical modification works with an enzyme that is specific to the
bacteria and antibiotic, such as in the case of Streptomycin which is an antibiotic that targets
Tuberculosis infections. Streptomycin binds to the small subunit rRNA which blocks the EFG activity which is responsible for translocation, thereby inhibiting the ribosomes from being
shifted into the P site in order to free up the A site for further protein synthesis (35). The next
mechanism involves enzymes that degrades the antibiotic until it is inactive. In Penicillin the
enzymes penicillinase are a class of β- lactamase enzymes which cleave the β- lactam ring
that is found in Penicillin. Finally, the last mechanism of antibiotic resistance includes the
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physical removal of the antibiotic from the cell. Efflux pumps are channels that actively
export antibacterial out of the cell utilizing ATP as an energy source or the concentration
gradient of hydrogen or sodium ions. This prevents the minimum inhibitory concentration
(MIC) to be reached which is necessary in order for the antibiotic to exhibit visible growth
inhibition after an overnight incubation (36). The use of an efflux pump is common in
Tetracycline, an antibiotic that combats a broad range of ailments from acne, urinary tract
infections, gonorrhea and chlamydia.
With the rapidly growing antibiotic resistance problem we are facing, there has been
an urgent need for novel antibiotics, as well as for mechanisms that reverse the antibiotic
resistance. Restoring antibiotic efficiency has been achieved with slow success through the
use of temperate phages to introduce genes that confer sensitivity. Streptomycin and nalidixic
acid has achieved success with the introduction of rpsL and gyrA genes relying on the phage’s
ability to deliver these genes, rather than the phage’s ability to kill the pathogens within the
host. This suggests that bacteria will be sensitive to the antibiotics (streptomycin and nalidixic
acid) before the host exhibits the infection (36).
While antibiotic resistance has plague bacteriostatic attempts, it has also burdened our
society with social and economic effects. The Centers for Disease Control and Prevention
estimates that in the United States $20 billion a year is spent on the healthcare effects of
antibiotic resistance and $35 billion a year on societal costs. Antibiotic resistance is also
estimated to have caused more than 8 million additional days of being admitted to the hospital
in 2011 alone and infected more than 2,049,442 people with 23,000 deaths (37).
Peptidoglycan is vital to the integrity and shape of the cell, thus is often the target for
many antibiotics. There have been antibiotics that target the biosynthesis of peptidoglycan,
however this method is prone to antibiotic resistance. An ideal target is stable, selectively
toxic and not likely to induce bacterial resistance, such as the enzymes that work on the
invariant glycan backbone of peptidoglycan, rather than the biosynthesis (38). N-
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Acetylglucosaminidases (GlcNAcases) is responsible, in part, for the remodeling and
recycling of peptidoglycan, therefore inhibiting GlcNAcase could yield a new spectrum of
antibiotics.
GlcNAcase
GlcNAcase are a class of autolysins which are involved in cell division, motility and the
assembly of macromolecules (1). GlcNAcases are broken up further into endo-glycosidases or
exo-glycosidases. Endo-glycosidases are enzymes that cleave the inner part of sugar chains
with a glycon specificity to entire glycan groups of the sugar chain, such as LytD in Bacillus
subtilis. Contrastingly, exo-glycosidases create small disaccharide products by cleaving the
monosaccharide that is located on the non- reducing terminal end of the sugar chain with,
found in LytG in Bacillus subtillus.

Figure 9: Pictured here is the composition of GlcNAc (39).
Interestingly, since exo-glycosidases have such high glycan specificity, they are ideal targets
for structural sugar studies, however the use of p-nitrophenyl glycosidase as a substrate does
not accurately mimic the structure since it is unable to hydrolyze p-nitrophenylglycosides.
Exoglycosidase activity can be accurately measured, however, with this method (40).
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GlcNAc is a monosaccharide derived from glucose, when alternated with N-acetylmuramic
acid (MurNAc), this biopolymer forms the layered peptidoglycan. Responsible for vegetative
cell growth and division in Gram-positive organisms (41), cytosolic exo-acting GlcNAcases
are known to be generated during peptidoglycan recycling (41).
Previous work has shown that glycosyl triazoles is a novel class of anti-bacterial agent (1).
Glycosyl triazoles can be prepared through a ‘click’ reaction which matches galactosyl and
glycosyl azides with an alkyne resulting in the inhibition of β- galactosidase and glycosidase
(42). Click chemistry relies on the ability to produce substances quickly through the
connections of smaller units. Glycosyl amines have been known to inhibit a large variety of
glycosidases by adding a positive charge on the active site which results in an interaction with
carboxylate aspect.
Work recently reported by Kahn published in 2014 in the Medicinal Chemistry
Communication, a Royal Society of Chemistry Journal, demonstrated growth inhibition of
two species, B. subtillus and B. cereus, in the micromolar range. These two inhibitors were
created through an Ugi – reaction which resulted in 1-azido-N-acetylglucosamide and a
plethora of terminal alkyne to be paired and tested for their ability to inhibit Gram-positive
bacterial growth. Using one of the Ugi-derived GNT B1.fgba, inhibition of nitrophenol
release was observed dependent of concentration when a synthetically- synthesized substrate
β-p-nitrophenyl GlcNAc (pNP-GlcNAc) was in the presence of B1.fgba with full inhibition at
250µm (1).
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Figure 10: B1.fgba which is the lead compound that our other inhibitors have come from, the
sugar is included as well (1).

METHODOLOGY
Getting to Know the Lab
Before beginning the Capstone research process I had to brush up on some simple techniques
which would be critical throughout the entirety of the research. A sample of these techniques
included:
1. Pipets
2. Autoclave
3. Fume Hood
4. Protein Gel
The pipets are used in order to precisely measure out a small aliquot of liquid that can then be
used to create solutions. The autoclave on the other hand is a tool used to sterilize equipment
utilizing extremely high pressure and heat. Both these tools are designed in order to promote
sterility which is a major focus when working with molecules such as proteins and enzymes.
Sterility allows researchers to ensure that the solutions and proteins they are utilizing are not
contaminated by other molecules that may be arbitrarily found in the air, which is not being
controlled for in experiments. When working with a procedure that requires sterility one will
often work in what is referred to as the fume hood. The fume hood is able to function by
diluting (sometimes hazardous) airborne material with air and drawing it through an exhaust
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system which can bring the air outside of the building (43). This also protects the researcher
as well as maintains a sterile environment to perform experiments that are easily contaminated
(i.e. spreading agar plates).

Figure 11: Proper position of the fume hood shield to prevent contamination and protect the
researcher from potentially hazardous material (43).
Electrophoresis is the main principle behind the sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) which allows for the separation of proteins utilizing an electric
field. The SDS buffer is a detergent which denatures the samples which allows the gel to no
longer be affected by protein shape. SDS also has a net negative charge (with an overall wide
range of pH) which allows for the proteins to effectively all be charged negative. Upon use of
SDS the proteins are able to be separated in the polyacrylamide gel solely by size and not
shape nor charge. Since all of the samples have a net negative charge they are now attracted
towards the positive anode which are at the bottom of the chamber (43). The larger molecules
will have a more difficult time passing through the gel and thus won’t be able to travel as far
as the smaller molecules, which allows for the separation by size. After applying about 150
volts to the chamber for over an hour the samples begin to separate out revealing the
molecular mass of protein, a defining quantitation. By comparing our samples to a
standardized ladder we can easily assess the estimated molecular mass (in kiloDaltons).
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Figure 12: Depiction of the experimental technique of an SDS-PAGE gel (44).
Protein Purification
Before we could begin experiments that aimed to better understand the enzymatic activity and
enzyme- substrate interaction we had to purify our protein of interest- LytG from B. subtilis.
In order to purify our protein we had to first clone a 6xHis-tag residue onto the LytG protein
and expressed it in Escherichia coli (E. coli). This will later allow us to exploit the 6xHis-tag
to bind Nickel. Lysozyme and RNAase was added to a solution of Lysis Buffer (Appendix A)
and our LytG pellets to lyse the cell wall and release our protein into solution. After brief
incubation and sonication the cells were centrifuged for 15 minutes at 4ºC at 15 x g. This
allows the heavy material from the cells to collect at the bottom and form a pellet, leaving the
lighter material, including our LytG protein, in solution. To further purify our solution we
passed it through a 2 μm filter to collect the lipids that we do not want to observe in our
experiments.
After separation by weight and size Immobile Metal-Affinity Chromatography (IMAC) was
used to exploit the unique affinity between Nickel and the 6xHis-tag residue. Two different
buffer solutions were used to run this program of purification a binding buffer with a pH of
about 8.0 and an elution buffer of a pH of about 4.5. These two buffers are each given a line
that connects them to a gradient mixer which controls the pH that leaves into one line. This
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one line is then connected to the column which contains our sample of somewhat purified
protein as well as the Nickel resin which is able to bind to the Histidine residues on the LytG
surface. When the gradient first starts the program we have a very high pH of 8.0 which
allows for the Nickel resin to bind to the protein while the rest of the solution passes through
and elutes off. After a few minutes the gradient mixer begins to slowly reduce the pH to a
final pH of 4.5. This allows for the histidine residues on the surface of the protein to become
protonated because it is becoming more acidic and allows for the protein to elute off of the
Nickel resin column.

IMAC pH Buffer Gradient
100
90

% pH 4.5 Buffer

80
70
60
50
40
30
20
10
0
0

10

20

25

30

35

Time

Figure 13: % pH 4.5 Buffer v. Time representation of the pH gradient of the IMAC gradient
mixer (45).
The entire time this binding and elution is occurring a UV monitor is recording the
absorbance of the sample, so as the protein elutes off of the column the UV monitor will
record on the chromatogram what is referred to as a protein peak.
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Figure 14: Chromatogram of LytG protein purification which identifies the start of the
protein peak at about 1200 seconds and the end at about 1500 seconds (46).
Solution is being collected in what is known as a fraction collector which spins at 2 minutes a
tube and allows for us to calculate which tube contains our protein. (In this chromatogram the
protein peak starts at 1200 seconds, which divided by 120 seconds/ tube, is tube 10 and ends
at 1500 seconds or tube 13. Therefore we would then collect the solution in tubes 10-13.

In order to find the concentration of the protein that we had in the purified solution of protein
we had to utilize the unique characteristic of a protein which is the extinction coefficient. This
is a value that is measured with a UV spec at 280nm and represents the ability of a protein to
absorb light. For LytG the extinction coefficient is 1g/L = 1.227 Abs (0.1%). Therefore after
we are able to measure a small 600μL sample at 280nm in the UV spec all we have to do is
make a ratio to solve for concentration.

Scheme 1: Calculation of LytG protein concentration using 0.1% Abs at 280nm.
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In this purification we were only able to get 0.2826 mg/mL of protein which was somewhat
low, most often we were able to get at least 0.65mg/mL of protein with about 5mL of sample.
This meant that on average we purified only about 3.25mg/mL of protein with each run and
after about 7-10 days these samples would run off and no longer be viable for testing.
Turbidity Assay
After about a week of prepping and performing the purification we are able to start a turbidity
assay which can, after several computations, tell us our Inhibitory Concentration 50 (IC50).
This is the value at which our compound, fgkc, is able to inhibit 50% of the bacterial growth,
which an industry standard to compare the efficiency of a spectrum of compounds. We used
the UV spec which was used to determine the protein concentration again to perform these
experiments. We utilized a standard of reaction buffer (Appendix B) to help cancel out
superfluous noise that may be picked up and then compared it to our sample of fgkc, PG,
reaction buffer and right before starting the spec, we add our LytG protein (APPENDIX C).
This is a qualitative measure that aims to judge the ability of our inhibitors quickly, but it also
allows us to establish a baseline. For each run we tested varying concentrations of our fgkc
(95μM, 50 μM, 20 μM, 0 μM) as well as a Dimethyl Sulfoxide (DMSO) control which was
expected to have zero inhibition. Each concentration was done in triplicates to account for
human error as well as technical variations. Each individual sample took 15 minutes to
analyze on the UV spec, which meant that each run took roughly four hours to perform plus
the time to create each sample. The absorbance of each sample for the first 65-70 seconds is
then taken at every 5 seconds which allows us to begin to create usable data that tells us about
the effectiveness of our compound. First, the % initial OD is calculated for each time point by
dividing the absorbance at the time point over the absorbance at T=0. These new values were
then plotted on a graph of % initial OD vs. time and the slopes were recorded for each sample.
The average slope of the DMSO control samples was then calculated, each samples slope was
then divided by this average. This value was a measurement of % residual activity in these
samples, once these averages were plotted on a graph we could use the equation of the line to
solve for y=0.5 for the IC50.
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Assay for Non-Specific Binding
Bovine Serum Albumin (BSA) is a protein that is found in cattle and is used in assay to assess
an inhibitors specificity against proteins. BSA is considered a “sticky” protein in terms of its
affinity for inhibitors and other molecules, which makes it an ideal candidate to test if our
compounds are specifically inhibiting LytG or if they are working by non-specifically killing,
which would make it a less “druggable” compound. The BSA assays were set up in 96 well
plates and, in technical duplicates, varied both concentration of the BSA protein as well as the
concentration of the fgkc which allowed us to assess the impact of these varying
concentrations on bacterial growth (Appendix D). We had a row of control which contained
DMSO, Luria Broth media and BSA. Every other well contained a different amount of fgkc,
Luria Broth media, BSA protein, and then as soon as all of the wells were filled (about 400
pipet tips later) we added our B. subtilis inoculum and allowed three hours of incubation
(Appendix E). After the incubation period we added a final compound to each well, Remazol
which changes color when in the presence of redox reactions which occurs when bacteria is
able to grow. At first all of the wells are a deep purple, but after about 15-20 minutes the color
begins to change, most prominently in our control well, which we expected bacterial growth
in.
Saturation Transfer Difference –Nuclear Magnetic Resonance
Saturation transfer difference nuclear magnetic resonance (STD-NMR) is a tool used to
characterize the interaction between our protein of interest, LytG and the ligand, our diamide
inhibitors. This information can later be used to better understand what aspects of our
inhibitors are the characteristics that confer the inhibitory activity and potency to the
molecule. Currently an undergraduate student at Brown University is working to adapt
protocols and conditions from a paper, “Ligand-Receptor Binding Affinities from Saturation
Transfer Difference Nuclear Magnetic Resonance Spectroscopy: The Binding Isotherm of
STD Initial Growth Rates” (47) using L-tryptophan and BSA to work for our LytG and
diamide inhibitors.
STD-NMR utilizes an extremely strong magnetic field, stronger than the Earth’s gravitational
pull, which aligns all of the hydrogen atoms poles with the pole of the giant magnet. These
hydrogen act as small bar magnets within the overarching larger magnetic field, thus their
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north poles align with the giant magnet’s north pole and south with south. After all of the
hydrogens are properly lined up we apply a specific frequency of FM radiation to our protein
LytG which is a form of high energy. The FM radiation is able to impart high energy onto the
hydrogen atoms which in turn reverses the poles of these theoretical bar magnets, thus the
north poles on the hydrogens are now aligned with the south pole of the giant magnetic field.
Next we introduce our diamide inhibitor to our LytG protein which naturally interacts. When
the diamide inhibitor begins to interact with the high energy hydrogen atoms on the protein,
the hydrogen atoms on the diamide inhibitor that most closely interact with the protein gain
protein’s high energy. This forces the hydrogen atoms on the diamide inhibitor that are most
closely reacting with the protein to flip poles as well (their north is now aligned with the
magnetic field’s south). Since this is a high energy state we are able to monitor the fall of
energy these hydrogen atoms (on the diamide inhibitor) experience which emits a signal (48).
This data is crucial in determining which aspects of our inhibitor are most important in the
LytG interaction. Since the paper we are adapting the protocol from utilizes L-Tryptophan
and BSA, the conditions for LytG and our diamide inhibitors are slightly different. Some of
the parameters this student is working on is the length of time the FM radiation should be
applied to our protein, at what intensity of FM radiation should we hit our protein and, finally,
how long our protein should be able to adjust to the high energy state. Soon we hope to
identify the correct parameters that give us data that helps to elucidate the LytG- diamide
inhibitor interaction.

RESULTS
Protein Purification
In order to ensure that our purification method was successful in isolating our protein of
interest we ran an SDS-PAGE gel. By separating our sample out by size and comparing it to a
standardized ladder we will be able to confirm if the protein we have purified is the correct
molecular mass (about 45kDa). Figure 15 depicts the gel after our first purification protocol,
which confirms the presence of solely our protein of interest.
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yr
Figure 15: Depiction of an SDS-PAGE gel which confirms the presence of LytG after
purification immobilized metal-affinity chromatography (Broad Range). Lane 1 is the BioRad
Standard Protein Ladder, Lane 2 is our LytG purified protein and Lane 3 is our affinity
column flow through which contains some membrane proteins which can be seen (49).
Turbidity Assay
After the first two trials of turbidity assay we were still getting data that indicated an IC50 in
the hundreds which we recognized to be somewhat inconsistent with the rest of the data we
had collected to date. We did a little investigating and realized that the fgkc compound that
was a crucial aspect of the assay composition had degraded thus the enzyme was no longer
active. We have since been able to run the assay once more with new compound and have
gathered data that is much more aligned with the rest of our data. Currently our IC50 is at
17.8μM, which is still higher than we expected but that may be due to technical error since the
protocol requires such precision. We plan to iron out a few more trials to make sure that our
data is correct.
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Figure 16: The % residual activity with our fgkc compound resulting from the turbidity assay
(50).
Assay for Non-Specific Binding
BSA assays are inherently qualitative which requires the use of human estimation to
transform them into graphical representations. The concentration of BSA is plotted on the xaxis and the apparent minimum inhibitory concentration (MIC) is plotted on the y-axis. This
y-axis value is derived from looking at the 96 well plates and identifying at what fgkc
concentration does the color change from purple, to pink- indicating bacterial growth.
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Figure 17: Before the Remazol color agent is allowed to incubate for 15 -20 minutes all of the
wells remain purple. After this period the wells that had bacterial growth begin to turn purple
(51) Please refer to Appendix D.
For almost every concentration of BSA the apparent MIC was at the lowest concentration of
fgkc was the 1/128 concentration of 0.107mg/mL, however since this was the lowest
concentration we could not see specifics from concentrations around that range. Thus, in the
future we plan to run a subsequent BSA assay with concentrations of fgkc closer to the range
of 0.107mg/mL instead of higher concentrations.
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Figure 18: The concentration of BSA was plotted versus the apparent MIC which yielded an
almost horizontal line indicated that our inhibitor binds specifically. If the slope had been
steep it would have indicated non-specific binding (52).
DISCUSSION
This research is considered discovery science in that we have created a library of aglycone
compounds which may or may not exhibit inhibitory characteristics and have slowly twiddled
down the list to potentially lethal targets. Our two best compounds to date have remained fgkc
and fgka, which we plan to continue researching way to make them more potent and
effective. Some characteristics have already been identified to understand what makes these
two compounds efficient while others are not. One of these features is the presence of an
Iodine atom off of the aglycone, we hope to identify more through the use of the STD-NMR.
Previous research using Triton detergent on these compounds have also supported the notion
that these compounds do not work by simply aggregate onto the surface of proteins to kill
them, and paired with the specific binding results of the BSA assay these compounds continue
to look promising.
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CONCLUSION
Moving forward we plan to keep working towards biochemically characterizing these
interactions so that we may gain a better perspective of what makes these compounds
effective inhibitors. In doing so we must re-do the turbidity assays so that we can get a clearer
picture of the inhibitory activity. We also must repeat another trial of the BSA assay so that
we can pin point the MIC with confidence rather than a rough estimate. We also hope to
produce some STD-NMR data soon to gain further insight. Finally, one of the bigger issues
was that our compounds are remaining water insoluble meaning that they cannot dissolve in
water which makes experiments down the road much more tenuous and difficult so we are
hoping to modify that characteristic.
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APPENDICES
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Appendix A – (Lysis Buffer)
50mM Na2HPO4
400mM NaCl
10% Glycerol
pH 8.0
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Appendix B – (IMAC Buffers)
Reaction Buffer:
10mM Sodium Citrate
10mM Magnesium Chloride
0.01% Triton X-100

Elution Buffer:
50mM Na2HPO4
400mM NaCl
10% Glycerol
pH 4.5
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Appendix C – (Turbidity Assay Protocol)
25mL lysis buffer for 3 pellets, keep on ice and add 10 μL lysozyme and miniscule amount of
RNAase. Sonicate for 4 minutes (10s on/ 20s off 60% Intensity). Centrifuge at 10,000 rpm for
15 minutes at 4ºC and pass supernatant through a 2μm filter.
Add 1mL of Nickel resin to Eppendorf and centrifuge briefly several times adding reaction
buffer between each cycle.
Load Nickel Resin on to column and allow to incubate overnight.
Load sample onto column slowly and follow with 2 mL of pH 8.0 buffer.
Purge both lines with water to get rid of air bubbles and ethanol which could form salts, for
several minutes.
Run with 100% pH 8.0 buffer for 3 minutes
Run program and run fraction collector simultaneously while watching for protein peak on the
chromatogram.
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Appendix D – (BSA 96-Well Plate set-up)
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Appendix E – (BSA Protocol)
Each well contains:
2 μL BSA
2 μL fgkc
91 μL LB Media
5 μL inoculum (1/20 dilution of OD600=1.0)
Control contains:
2 μL DMSO
93 μL LB Media
5 μL inoculum
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